Assyro AI

Orange Book product · Generic (ANDA)

DAPIPRAZOLE HYDROCHLORIDE

DAPIPRAZOLE HYDROCHLORIDE

Generic (ANDA)ANDA 204902DISCN BARADAINA LLC

At a glance

May 30, 2019

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    May 30, 2019

    7 yr 2 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

DAPIPRAZOLE HYDROCHLORIDE

Strength

0.5%

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

TE code

Not listed

Application

ANDA 204902

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of DAPIPRAZOLE HYDROCHLORIDE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.